Trust Point Inc. Repligen Corp Transaction History
Trust Point Inc.
- $1.1 Trillion
- Q1 2025
A detailed history of Trust Point Inc. transactions in Repligen Corp stock. As of the latest transaction made, Trust Point Inc. holds 3,756 shares of RGEN stock, worth $488,280. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,756
Previous 5,786
35.08%
Holding current value
$488,280
Previous $833 Million
42.62%
% of portfolio
0.04%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
486Shares Held
56.5MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$984 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$928 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$663 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$220 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$201 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.21B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....